FOXD2 and thyroid cancer: Therefore, our results provide new insights into the mechanism that clarifies the function of FOXD2-AS1 in thyroid cancer, supporting the idea that FOXD2-AS1 can serve as a novel recurrent marker or a potential target in thyroid cancer.